Skip to content

Inspiratory Muscle Endurance of Adults

Determination of Respiratory Muscle Endurance in Healthy Adult Individuals

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05237427
Enrollment
112
Registered
2022-02-14
Start date
2020-09-01
Completion date
2023-01-18
Last updated
2023-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The aim of this study is to determine the reference value ranges for healthy adults of the incremental threshold load test, which evaluates respiratory muscle endurance.

Detailed description

Since respiratory muscles are used in daily life at the submaximal level, evaluation of their endurance is more meaningful functionally. In addition, evaluation of endurance with respiratory muscle strength is effective in determining respiratory muscle dysfunction. Failure to routinely evaluate respiratory muscle endurance, which is one of the main components of respiratory muscle function, may lead to failure to identify respiratory muscle dysfunction in early stage respiratory patients who have not yet developed muscle strength loss. However, normal value ranges have not been determined for the respiratory muscle endurance test. Determining the normal value ranges for this test will help determine muscle fatigue and investigate the physiological course in respiratory diseases.

Interventions

None listed

Sponsors

Kutahya Health Sciences University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Being between the ages of 18-35 * Not having any disease * Not exercising regularly * Not smoking

Exclusion criteria

* Having a respiratory disease * Have heart disease * Have a neuromuscular disease * Have Scoliosis * Having had thoracic surgery * Having experienced the respiratory muscle endurance protocol before

Design outcomes

Primary

MeasureTime frameDescription
Maximal inspiratory pressure20 minuteA measure of the strength of inspiratory muscles
Incremental threshold loading test.15 minuteA measure of endurance of inspiratory muscles.

Secondary

MeasureTime frameDescription
Pulmonary function test - Forced vital capacity (FVC)5 minuteForced vital capacity (FVC) is lung function test that are measured during spirometry. This pulmonary function test measurement is applied to confirm that the respiratory function parameters of the participants were within the normal range.
International Physical Activity Questionnaire - Short Form5 minuteThis questionnaire assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in the metabolic equivalent of task (MET)-minute/week and time spent sitting.
Maximal voluntary ventilation (MVV)5 minuteIt is a test that measures inspiratory endurance. MVV is the largest amount of air that a person can inhale and then exhale during a 12- to 15-s interval with maximal voluntary effort. It is determined by spirometry measurement.
Pulmonary function test - Forced expiratory volume in 1 second (FEV1)5 minuteThe forced expiratory volume in 1 second (FEV1) is the volume of air (in liters) exhaled in the first second during forced exhalation after maximal inspiration. It is lung function test that are measured during spirometry. This pulmonary function test measurements were made to confirm that the respiratory function parameters of the participants were within the normal range. .

Other

MeasureTime frameDescription
Anthropometric assessment5 minuteBody weight was assessed with a digital scale in the orthostatic position, without shoes, with minimal clothing. Height was measured with the feet parallel and adjacent to each other, the arms extended by the body, and the head in a neutral position. Correlations between inspiratory muscle endurance of the incremental threshold loading protocol and anthropometric characteristics will be shown.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026